Catalyst Pharmaceuticals Inc (CPRX): Eigentümerstruktur Nicht notiert
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 31,667 US Dollar | 6 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 122.417.458 | 6,78 | 4,11 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Catalyst Pharmaceuticals Inc
Mitarbeiter 182
Handelsplatz NASDAQ
Ticker Symbol CPRX
IPO Datum 2006-11-08
Adresse 355 Alhambra Circle, Coral Gables, FL, United States, 33134
Webseite https://catalystpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Patrick J. McEnany | Co-Founder & Non-Executive Chairman |
| 2 | Mr. Richard John Daly M.B.A. | President, CEO & Director |
| 3 | Mr. Michael W. Kalb CPA | Executive VP, Treasurer & CFO |
| 4 | Dr. Steven R. Miller Ph.D. | Executive VP, COO & Chief Scientific Officer |
| 5 | Mr. Jeffrey Del Carmen | Executive VP & Chief Commercial Officer |
| 6 | Dr. William T. Andrews FACP, M.D. | Chief Medical Officer |
| 7 | Ms. Mary Coleman | VP & Head of Investor Relations |
| 8 | Mr. Brian Elsbernd J.D. | Chief Compliance Officer & Chief Legal Officer |
| 9 | Mr. Gregg Russo | Chief Human Resources Officer |
| 10 | Dr. Preethi Sundaram Ph.D. | Chief Strategy Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 15,34% | 0,59 Mrd. USD |
| 2 | Vanguard Group Inc | 6,89% | 0,27 Mrd. USD |
| 3 | State Street Corp | 5,61% | 0,22 Mrd. USD |
| 4 | Vanguard Capital Management, LLC | 4,18% | 0,16 Mrd. USD |
| 5 | American Century Companies Inc | 3,38% | 0,13 Mrd. USD |
| 6 | Deerfield Management Co | 3,22% | 0,12 Mrd. USD |
| 7 | Dimensional Fund Advisors, Inc. | 2,80% | 0,11 Mrd. USD |
| 8 | Bank of America Corp | 2,48% | 0,10 Mrd. USD |
| 9 | Geode Capital Management, LLC | 2,43% | 0,09 Mrd. USD |
| 10 | Morgan Stanley - Brokerage Accounts | 2,20% | 0,09 Mrd. USD |
| 11 | Vanguard Portfolio Management, LLC | 2,02% | 0,08 Mrd. USD |
| 12 | Renaissance Technologies Corp | 1,92% | 0,07 Mrd. USD |
| 13 | Royce & Associates, LP | 1,71% | 0,07 Mrd. USD |
| 14 | HHG PLC | 1,63% | 0,06 Mrd. USD |
| 15 | Boston Partners Global Investors, Inc | 1,40% | 0,05 Mrd. USD |
| 16 | Charles Schwab Investment Management Inc | 1,17% | 0,05 Mrd. USD |
| 17 | Northern Trust Corp | 1,01% | 0,04 Mrd. USD |
| 18 | Kennedy Capital Management Inc | 0,98% | 0,04 Mrd. USD |
| 19 | UBS Group AG | 0,81% | 0,03 Mrd. USD |
| 20 | The Goldman Sachs Group Inc | 0,80% | 0,03 Mrd. USD |